Harder, Michelle T.
Mokete, Moliehi
Chammartin, Frédérique
Lerotholi, Malebanye
Motaboli, Lipontso
Kopo, Mathebe
Kao, Mpho
Mokebe, Moleboheng
Chejane, Ntoiseng
Mahlatsi, Palesa
Nyakane, Morongoe
Tarumbiswa, Tapiwa
Labhardt, Niklaus D.
Tschumi, Nadine
Belus, Jennifer M.
Funding for this research was provided by:
University of Basel
Article History
Received: 21 March 2024
Accepted: 20 September 2024
First Online: 1 October 2024
Declarations
:
: The study protocol has been approved by the National Health Research Ethics Committee (NH-REC) in Lesotho (ID 220–2019). All participants provided written informed consent for the VITAL trial and the nested qualitative study. In case of illiteracy, participants consented with a thumb print and a witness selected by the participant co-signed the consent form.
: Not applicable.
: NDL reports having received travel grants to attend scientific conferences from Gilead Sciences and ViiV Healthcare. In 2022 and 2023, his division at the University Hospital Basel received honoraria from ViiV Healthcare.